Carnegie acted as lead manager in the private placement of equity in Carmel Pharma AB, a company involved in the development of a medical device for eliminating exposure and contamination by cytostatic and antiviral drugs.January, 1999.
Healthcare
Private placement of equity in Carmel Pharma AB (SE) — SEK 20 million
January 1999